(3-aminomethyl-6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amine | 844874-05-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: (3-aminomethyl-6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amine
• 英文别名: 3-Aminomethyl-6-chloro-1,2,3,4-tetrahydroacridin-9-ylamine；3-(aminomethyl)-6-chloro-1,2,3,4-tetrahydroacridin-9-amine
• CAS: 844874-05-1
• 化学式: C₁₄H₁₆ClN₃
• 分子量: 261.754
• InChiKey: XNHOJLIQFFHLQI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  64.9
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(1,2-二硫烷-3-基)乙酸 、 (3-aminomethyl-6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amine 在 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.25h， 以40%的产率得到N-(9-Amino-6-chloro-1,2,3,4-tetrahydro-acridin-3-yl-methyl)-2-[1,2]dithiolan-3-yl-acetamide
  参考文献：
  名称：

  Organic Compounds Useful For The Treatment Of Alzheimer's Disease, Their Use And Method Of Preparation

  摘要：

  通式(I)所识别的化合物用于治疗阿尔茨海默病。

  公开号：

  US20070219241A1
• 作为产物：
  描述：

  3-(nitromethyl)cyclohexanone 、 2-氨基-4-氯苯腈 以30%的产率得到(3-aminomethyl-6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amine
  参考文献：
  名称：

  Organic Compounds Useful For The Treatment Of Alzheimer's Disease, Their Use And Method Of Preparation

  摘要：

  通式(I)所识别的化合物用于治疗阿尔茨海默病。

  公开号：

  US20070219241A1

文献信息

• Tetrahydro-acridine and dithiolane derivatives
  申请人：Alma Mater Studiorum-Universita'di Bologna

  公开号：US07307083B2

  公开（公告）日：2007-12-11

  Compounds identified by the general formula (I) are used for the treatment of Alzheimer's disease

  通式（I）所识别的化合物用于治疗阿尔茨海默病。
• Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
  申请人：Rosini Michela

  公开号：US20070299093A1

  公开（公告）日：2007-12-27

  Compounds identified by the general formula (I) are used for the treatment of Alzheimer's disease.

  通式（I）所识别的化合物被用于治疗阿尔茨海默病。
• Rational Approach To Discover Multipotent Anti-Alzheimer Drugs
  作者：Michela Rosini、Vincenza Andrisano、Manuela Bartolini、Maria L. Bolognesi、Patrizia Hrelia、Anna Minarini、Andrea Tarozzi、Carlo Melchiorre

  DOI：10.1021/jm049112h

  日期：2005.1.1

  The coupling of two different pharmacophores, each endowed with different biological properties, afforded the hybrid compound lipocrine (7), whose biological profile was markedly improved relative to those of prototypes tacrine and lipoic acid. Lipocrine is the first compound that inhibits the catalytic activity of AChE and AChE-induced amyloid-beta aggregation and protects against reactive oxygen species. Thus, it emerged as a valuable pharmacological tool to investigate Alzheimer's disease and as a promising lead compound for new anti-Alzheimer drugs.
• ORGANIC COMPOUNDS USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE, THEIR USE AND METHOD OF PREPARATION
  申请人：Alma Mater Studiorum -Universita' di Bologna

  公开号：EP1853594A2

  公开（公告）日：2007-11-14
• US7307083B2
  申请人：——

  公开号：US7307083B2

  公开（公告）日：2007-12-11